Race, ethnicity and risk of second primary contralateral breast cancer in the United States.
Adult
Black or African American
/ statistics & numerical data
Aged
Breast Neoplasms
/ epidemiology
Female
Hispanic or Latino
/ statistics & numerical data
Humans
Middle Aged
Neoplasm Staging
Neoplasms, Second Primary
/ epidemiology
Prophylactic Mastectomy
Proportional Hazards Models
Risk Assessment
SEER Program
United States
/ ethnology
Young Adult
contralateral breast cancer
ethnicity
race
second primary cancer
survivorship
Journal
International journal of cancer
ISSN: 1097-0215
Titre abrégé: Int J Cancer
Pays: United States
ID NLM: 0042124
Informations de publication
Date de publication:
01 06 2021
01 06 2021
Historique:
revised:
12
01
2021
received:
10
11
2020
accepted:
14
01
2021
pubmed:
6
2
2021
medline:
14
9
2021
entrez:
5
2
2021
Statut:
ppublish
Résumé
Breast cancer survivors have a high risk of a second primary contralateral breast cancer (CBC), but there are few studies of CBC risk in racial/ethnic minority populations. We examined whether the incidence and risk factors for CBC differed by race/ethnicity in the United States. Women with a first invasive Stage I-IIB breast cancer diagnosis at ages 20-74 years between 2000 and 2015 in the Surveillance, Epidemiology, and End Results Program (SEER) 18 registries were followed through 2016 for a diagnosis of invasive CBC ≥1 year after the first breast cancer diagnosis. We used cause-specific Cox proportional hazards models to test the association between race/ethnicity and CBC, adjusting for age, hormone receptor status, radiation therapy, chemotherapy and stage at first diagnosis, and evaluated the impact of contralateral prophylactic mastectomy, socioeconomic status, and insurance status on the association. After a median follow-up of 5.9 years, 9247 women (2.0%) were diagnosed with CBC. Relative to non-Hispanic (NH) White women, CBC risk was increased in NH Black women (hazard ratio = 1.44, 95% CI 1.35-1.54) and Hispanic women (1.11, 95% CI 1.02-1.20), with the largest differences among women diagnosed at younger ages. Adjustment for contralateral prophylactic mastectomy, socioeconomic status and health insurance did not explain the associations. Therefore, non-Hispanic Black and Hispanic women have an increased risk of CBC that is not explained by clinical or socioeconomic factors collected in SEER. Large studies of diverse breast cancer survivors with detailed data on treatment delivery and adherence are needed to inform interventions to reduce this disparity.
Identifiants
pubmed: 33544892
doi: 10.1002/ijc.33501
pmc: PMC9059169
mid: NIHMS1788130
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
2748-2758Subventions
Organisme : NCI NIH HHS
ID : R01CA129639
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA097397
Pays : United States
Organisme : NCI NIH HHS
ID : R01CA114236
Pays : United States
Organisme : NCI NIH HHS
ID : R01CA097397
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States
Organisme : NCI NIH HHS
ID : U01 CA083178
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA129639
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA114236
Pays : United States
Organisme : NCI NIH HHS
ID : U01CA083178
Pays : United States
Informations de copyright
© 2021 UICC.
Références
Breast Cancer Res. 2017 Jul 19;19(1):83
pubmed: 28724391
J Natl Cancer Inst. 2009 Aug 5;101(15):1058-65
pubmed: 19590058
Breast Cancer Res. 2004;6(3):R199-214
pubmed: 15084244
Breast Cancer Res Treat. 2010 Oct;123(3):627-35
pubmed: 20571870
Springerplus. 2016 Jan 06;5:14
pubmed: 26759753
PLoS One. 2017 May 3;12(5):e0176417
pubmed: 28467490
Breast Cancer Res Treat. 2012 Jul;134(2):769-81
pubmed: 22562122
J Am Coll Radiol. 2017 Feb;14(2):157-165.e9
pubmed: 27993485
Cancer. 2008 Oct 15;113(8):2166-72
pubmed: 18798230
Cancer Causes Control. 2018 Jul;29(7):611-618
pubmed: 29846844
Natl Vital Stat Rep. 1998 Oct 7;47(3):1-16, 20
pubmed: 9796247
Ann Surg Oncol. 2016 May;23(5):1537-42
pubmed: 26714953
Breast Cancer Res Treat. 2010 Jan;119(1):145-53
pubmed: 19731015
Cancer Causes Control. 2001 Oct;12(8):703-11
pubmed: 11562110
J Clin Med. 2018 May 31;7(6):
pubmed: 29857526
Breast Cancer Res Treat. 2015 Jun;151(3):687-96
pubmed: 26012645
Am J Epidemiol. 1992 Oct 15;136(8):925-36
pubmed: 1456269
Cancer Epidemiol Biomarkers Prev. 2009 Oct;18(10):2579-99
pubmed: 19815634
J Natl Cancer Inst. 2019 Jul 1;111(7):709-718
pubmed: 30698719
Int J Radiat Oncol Biol Phys. 2008 Nov 15;72(4):1021-30
pubmed: 18556141
Med Care. 2016 Sep;54(9):e55-64
pubmed: 24638121
Ann Surg. 2017 Mar;265(3):581-589
pubmed: 28169929
Ethn Dis. 2018 Oct 18;28(4):565-574
pubmed: 30405302
Cancer Med. 2016 Nov;5(11):3282-3291
pubmed: 27700016
CA Cancer J Clin. 2019 Nov;69(6):438-451
pubmed: 31577379
Breast Cancer Res Treat. 2017 Jul;164(1):139-147
pubmed: 28365834
Cancer Causes Control. 2014 Jan;25(1):81-92
pubmed: 24178398
J Natl Cancer Inst. 2008 Jan 2;100(1):32-40
pubmed: 18159070
Surgery. 2018 Aug;164(2):195-200
pubmed: 29731247
Epidemiol Rev. 2014;36:114-36
pubmed: 24375928
Breast Cancer Res Treat. 2014 Nov;148(1):163-73
pubmed: 25261293
Breast Cancer Res Treat. 2011 Oct;129(3):963-9
pubmed: 21553293
JAMA. 2012 Feb 1;307(5):491-7
pubmed: 22253363
J Natl Cancer Inst. 2019 May 1;111(5):498-508
pubmed: 30239824
Cancer Epidemiol Biomarkers Prev. 2011 Feb;20(2):389-96
pubmed: 21217087
J Clin Oncol. 2010 Sep 20;28(27):4135-41
pubmed: 20697082
Hum Pathol. 2019 Oct;92:1-9
pubmed: 31351153
J Clin Oncol. 2010 May 10;28(14):2404-10
pubmed: 20368571
Am J Surg. 2013 Nov;206(5):704-8
pubmed: 24016706